Ruggaard & Associates’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $348K | Hold |
446
| – | – | 0.14% | 85 |
|
|
2025
Q1 | $368K | Buy |
446
+3
| +0.7% | +$2.48K | 0.16% | 81 |
|
|
2024
Q4 | $342K | Sell |
443
-133
| -23% | -$103K | 0.15% | 82 |
|
|
2024
Q3 | $510K | Hold |
576
| – | – | 0.22% | 64 |
|
|
2024
Q2 | $521K | Buy |
576
+9
| +2% | +$8.15K | 0.24% | 62 |
|
|
2024
Q1 | $441K | Buy |
567
+12
| +2% | +$9.34K | 0.21% | 67 |
|
|
2023
Q4 | $324K | Sell |
555
-15
| -3% | -$8.74K | 0.17% | 83 |
|
|
2023
Q3 | $306K | Sell |
570
-14
| -2% | -$7.52K | 0.18% | 78 |
|
|
2023
Q2 | $274K | Sell |
584
-39
| -6% | -$18.3K | 0.16% | 89 |
|
|
2023
Q1 | $214K | Buy |
+623
| New | +$214K | 0.13% | 97 |
|